CA Stock MarketDetailed Quotes
XPHY XPhyto Therapeutics Corp
- 0.510
- 0.0000.00%
15min DelayMarket Closed Nov 11 16:00 ET
46.52MMarket Cap-2684P/E (TTM)
0.000High0.000Low0Volume0.000Open0.510Pre Close0.00Turnover0.53052wk High0.00%Turnover Ratio91.21MShares0.48052wk Low-0.19EPS TTM42.99MFloat Cap3.550Historical HighLossP/E (Static)84.30MShs Float0.360Historical Low-0.29EPS LYR0.00%Amplitude--Dividend TTM30.00P/B1Lot Size--Div YieldTTM
XPhyto Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 45.25%-1.9M | 74.67%-1.17M | -19.11%-12.16M | 13.10%-1.63M | 12.44%-2.47M | -20.06%-3.46M | -74.68%-4.6M | -176.53%-10.2M | -52.62%-1.87M | -130.76%-2.82M |
| Net income from continuing operations | 67.51%-1.35M | 67.20%-1.76M | -22.19%-20.64M | -203.10%-8.51M | 61.79%-2.6M | -15.84%-4.16M | -45.54%-5.37M | -120.24%-16.89M | -28.13%-2.81M | -82.27%-6.8M |
| Operating gains losses | 3,887.92%76.61K | 227.01%45.18K | -103.93%-3.6K | 253.25%26.94K | -95.59%3.11K | 110.78%1.92K | -163.25%-35.57K | 339.09%91.36K | -194.82%-17.58K | --70.53K |
| Depreciation and amortization | -63.95%74.4K | -71.88%59.13K | -8.17%823.22K | -4.46%201.79K | -3.16%204.77K | -17.50%206.37K | -5.98%210.29K | -5.16%896.47K | -14.73%211.22K | -17.26%211.46K |
| Asset impairment expenditure | ---- | ---- | 87.77%3.68M | ---- | ---- | ---- | ---- | 340.72%1.96M | --0 | ---- |
| Remuneration paid in stock | -92.06%26.38K | -94.59%48.54K | 26.31%3.28M | 296.98%2.04M | -99.48%5.83K | 345.86%332.15K | 1.16%896.65K | 46.22%2.59M | 261.03%514K | -25.51%1.12M |
| Deferred tax | ---- | ---- | 69.02%-110.74K | ---- | ---- | ---- | ---- | -694.05%-357.49K | -157.74%-116.04K | ---163K |
| Other non cashItems | -202.47%-391.28K | -13.76%281.6K | -16.06%1.24M | 99.25%343.02K | -54.42%188.46K | 47.23%381.85K | -48.34%326.53K | 105.42%1.48M | 537.13%172.16K | -39.66%413.42K |
| Change In working capital | -47.97%-329.81K | 125.41%160.53K | -1,692.80%-418.73K | 308.64%704.37K | -171.10%-268.41K | -256.15%-222.89K | 5.18%-631.8K | -85.37%26.29K | 32.68%172.37K | 72.91%377.52K |
| -Change in receivables | -88.88%9.91K | 316.61%223.08K | -21.98%-214.53K | -172.36%-95.97K | -1,678.57%-104.66K | 284.39%89.09K | 61.40%-102.98K | -1,094.15%-175.87K | 370.13%132.64K | 117.88%6.63K |
| -Change in inventory | 178.80%115.07K | ---47.38K | ---736.16K | ---377.41K | ---212.72K | ---146.03K | --0 | --0 | ---- | ---- |
| -Change in prepaid assets | 48.51%-69.84K | 149.63%48.53K | 683.60%75.63K | 137.50%345.78K | -240.79%-36.74K | -517.90%-135.63K | 54.96%-97.78K | 87.62%-12.96K | 2,591.34%145.59K | 128.92%26.1K |
| -Change in payables and accrued expense | -1,169.44%-384.95K | 85.22%-63.69K | 112.12%456.33K | 885.91%831.97K | -75.14%85.72K | -119.12%-30.32K | -136.31%-431.04K | -28.08%215.12K | -157.47%-105.86K | -0.44%344.79K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 45.25%-1.9M | 74.67%-1.17M | -19.11%-12.16M | 13.10%-1.63M | 12.44%-2.47M | -20.06%-3.46M | -74.68%-4.6M | -176.53%-10.2M | -52.62%-1.87M | -149.54%-2.82M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -3,292.27%-5.31M | -4,553.83%-4.27M | -10,159.54%-654.68K | -481.14%-357.09K | -152.63%-24.62K | 66.15%-156.47K | -988.97%-91.79K | 101.52%6.51K |
| Net PPE purchase and sale | --0 | --0 | -189.09%-452.35K | 85.72%-13.11K | -983.87%-57.52K | -481.14%-357.09K | -152.63%-24.62K | -59.22%-156.47K | -67.73%-91.79K | 281.43%6.51K |
| Net business purchase and sale | ---- | ---- | ---4.86M | ---4.26M | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | -3,292.27%-5.31M | -4,553.83%-4.27M | -10,159.54%-654.68K | -481.14%-357.09K | -152.63%-24.62K | 66.15%-156.47K | -988.97%-91.79K | 101.52%6.51K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -62.02%702.87K | -70.20%1.67M | 28.30%16.23M | 48.79%6.24M | 0.83%2.54M | 7.96%1.85M | 32.63%5.6M | 508.48%12.65M | 484.76%4.19M | 1,104.44%2.52M |
| Net issuance payments of debt | -69.81%-263.13K | -6.48%-38.22K | -55.67%1.87M | -23.03%2.1M | 84.93%-33.41K | -63.79%-154.95K | -101.98%-35.9K | 4,130.74%4.23M | 5,175.10%2.73M | -952.16%-221.62K |
| Net common stock issuance | --1.05M | -49.12%1.45M | --7.35M | --4.5M | --0 | --0 | --2.85M | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | -88.15%357K | -9.83%7.6M | --0 | -6.09%2.58M | 10.88%2.01M | 25.30%3.01M | 481.39%8.42M | 90.29%1.47M | 1,090.53%2.75M |
| Net other financing activities | ---84K | 56.16%-100K | ---589.58K | ---361.48K | --0 | --0 | ---228.1K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -62.02%702.87K | -70.20%1.67M | 28.30%16.23M | 48.79%6.24M | 0.83%2.54M | 7.96%1.85M | 32.63%5.6M | 508.48%12.65M | 484.76%4.19M | 1,104.44%2.52M |
| Net cash flow | ||||||||||
| Beginning cash position | -48.07%1.85M | -47.70%1.35M | 776.21%2.58M | 185.92%1.02M | 147.69%1.59M | 89.78%3.56M | 776.21%2.58M | -87.53%295.01K | -55.10%355.16K | -69.95%642.17K |
| Current changes in cash | 39.43%-1.19M | -48.30%503.68K | -153.84%-1.23M | -84.80%338.7K | -101.77%-574.88K | -59.88%-1.97M | -38.28%974.22K | 210.41%2.29M | 546.63%2.23M | 78.83%-284.92K |
| Effect of exchange rate changes | -668.01%-3.24K | -352.57%-6.04K | -174.13%-424 | -261.22%-2.2K | 90.71%-194 | 77.86%-422 | -25.33%2.39K | -80.45%572 | -53.38%1.36K | ---2.09K |
| End cash Position | -58.96%652.72K | -48.07%1.85M | -47.70%1.35M | -47.70%1.35M | 185.92%1.02M | 147.69%1.59M | 89.78%3.56M | 776.21%2.58M | 776.21%2.58M | -55.10%355.16K |
| Free cash from | 50.37%-1.9M | 74.81%-1.17M | -21.68%-12.61M | 16.50%-1.64M | 10.19%-2.52M | -29.68%-3.82M | -74.97%-4.62M | -171.98%-10.36M | -53.26%-1.96M | -144.76%-2.81M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data